Deep insights & analyses

Insights

Dive into comprehensive insights and analyses from Volv Global on the intersection of healthcare trends, innovations, and AI technology.

Case Study: Detecting signs of Fabry and Pompe disease in UK clinical data

Volv, supported by Sanofi, and working with Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing research

By Volv Global SA and WODC EU contributors Executive Summary For decades, the pharmaceutical industry has faced the same

By Christopher Rudolf, Volv Global Rare disease patients and the journey to diagnosis, treatment, and support For patients with rare

By Christopher Rudolf, Volv Global Rare disease patients and the journey to diagnosis, treatment, and support For patients with rare

By Christopher Rudolf, Volv Global Introduction Rare Disease Day highlights the voices, stories, and experiences of millions of people living

In this early collaboration with Alnylam Pharmaceuticals and the PHARMO Institute for Drug Outcomes Research, Volv Global applied a novel